Error loading player: No playable sources found

AM24-MN-34-O

AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)

Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 AABB Annual Meeting On-Demand: BIOTHERAPIES SESSIONS
Interested in all sessions Cellular Therapy/Biotherapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting…
Thumbnail for 2024 AABB Annual Meeting On-Demand: CABP CE Eligible Sessions
Interested in sessions eligible to maintain your AABB Certified Advanced Biotherapies Professional (CABP) certification? This package provides:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

CABP CE Eligible

Hematopoietic stem cells (HSCs) are the apex hematopoietic cell with the potential to produce robust and lifelong production of all blood cells. Thus, understanding the details of HSC molecular biology is critical to our understanding of human health and longevity. Mechanistic insights into HSC biology could be leveraged to further improve the strategies available to maintain and expand functional HSCs in vitro. Overcoming these hurdles is critical to effectively use HSCs for off-the-shelf allogeneic HSC transplantation or gene-editing of autologous HSCs for treatments of hematological disease and malignancies. In this session, we will discuss the most recent applications of HSC expansion technology currently in clinical use. We will also explore the latest mechanistic breakthroughs towards producing abundant HSCs in vitro for use in transfusion applications.

Learning Objectives

  • Uncover latest mechanistic underpinnings of hematopoietic stem cell (HSC) cycling and maintenance of stem cell self-renewal in vitro.
  • Define the molecular mechanisms and that contribute to exhaustion of HSCs under tissue culture conditions.
  • Describe the latest advances in technologies and methods to expand functional HSCs and de novo generation of HSCs in vitro.

Moderator

Speaker Image for Larry Luchsinger
New York Blood Center

Speakers

Speaker Image for Adam Wilkinson
Associate Professor Of Stem Cell Biology, University of Oxford

Related Products

Thumbnail for AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (Enduring)
AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (Enduring)
This session equips blood bank, transfusion medicine, and biotherapies professionals with practical tools for robust risk assessment. Risk identification methods and customizing risk registers for specific practice areas will be covered…
Thumbnail for AM24-TU-01-O: Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies (Enduring)
AM24-TU-01-O: Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies (Enduring)
Emerging chimeric antigen receptor (CAR) T cell technology has recently helped transform treatment options for cancer patients…
Thumbnail for AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection?  Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection? Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
This informative session will give an overview of inspections conducted by FDA’s Office of Inspections and Investigations (OII), Office of Biologics Inspectorate (OBI), including OBI’s role in regulatory inspections and current regulatory oversight…
Thumbnail for AM24-MN-32-O: Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think (Enduring)
AM24-MN-32-O: Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think (Enduring)
This session will highlight advances in three areas of platelet research; stabilization methods through lyophilization, iPSC ex-vivo production, and synthetic nanoparticle technology are converging and can lead to long-lived platelet-based therapies targeted to address specific related pathologies…